Centre Hospitalier Victor Dupouy Argenteuil

The site’s Service d’Hématologie is involved in research on hemic and lymphatic diseases, with a focus on Waldenström macroglobulinemia. These studies are designed to evaluate new treatment approaches for patients who have already received prior therapy, with the goal of improving disease control and tolerance.

• Waldenström macroglobulinemia in previously treated patients
• Hemic and lymphatic diseases and treatment response
• Testing a new therapy combination to improve effectiveness and tolerability

This area of research reflects the site’s expertise in blood disorders and supports efforts to expand options for people living with difficult-to-treat hematologic cancers.

Clinical research in respiratory tract diseases and bacterial infections includes studies in critically ill patients with ventilator-associated tracheobronchitis. The main aim is to determine whether an inhaled antibiotic strategy can help prevent worsening of infection and reduce the chance of progression to more serious lung disease.

• Ventilator-associated tracheobronchitis in ICU patients
• Bacterial infections in critically ill adults
• Evaluating whether treatment can lower the risk of progression to ventilator-associated pneumonia

This work addresses an important intensive care challenge by exploring ways to improve infection management and patient outcomes in hospitalized adults.